Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OCTA as a New Biomarker in the Pathogenesis of Primary Open Angle Glaucoma

NCT05455567 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT05455567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05455567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OCTA as a New Biomarker in the Pathogenesis of Primary Open Angle Glaucoma
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
May 15, 2022
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma open-angle primary